NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,618.00
-12.00 (-0.74%)
Mar 20, 2025, 9:00 AM KST

NGeneBio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
34,00932,41171,664116,027201,381
Market Cap Growth
-54.77%-54.77%-38.23%-42.38%-
Enterprise Value
36,26440,75456,79789,239-
Last Close Price
1716.001642.004897.308173.9214269.12
PS Ratio
4.285.7016.4710.5328.11
PB Ratio
1.831.834.414.585.92
P/TBV Ratio
3.543.544.974.916.23
EV/Sales Ratio
6.377.1613.058.10-
Debt / Equity Ratio
0.510.510.710.450.21
Asset Turnover
0.150.150.090.22-
Inventory Turnover
1.911.911.933.29-
Quick Ratio
0.660.660.981.253.22
Current Ratio
0.930.931.141.493.40
Return on Equity (ROE)
-82.15%-82.15%-61.88%-33.17%-
Return on Assets (ROA)
-26.71%-26.71%-17.05%-10.75%-
Return on Capital (ROIC)
-36.93%-36.93%-26.03%-13.78%-
Earnings Yield
-37.13%-38.96%-17.82%-8.43%-4.19%
FCF Yield
-36.95%-38.77%-13.33%-7.63%-5.24%
Buyback Yield / Dilution
-11.89%-11.89%-1.62%-0.89%-
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.